Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
JANSSEN NZ LIMITED,Guselkumab,"Psoriatic arthritis, 2nd line biologic",Guselkumab (TREMFYA),Options for investment,Community and Hospital,
